Regulatory Requirements for Interchangeable Biosimilar Designation.
Saved in:
| Title: | Regulatory Requirements for Interchangeable Biosimilar Designation. |
|---|---|
| Authors: | Samy PJ; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Mouslim MC; The Hilltop Institute, University of Maryland, Baltimore County, 1000, Hilltop Circle, Baltimore, MD, USA. mmousli1@umbc.edu.; Department of Health Management and Policy, University of Michigan, Ann Arbor, MI, USA. mmousli1@umbc.edu., Bennett CL; College of Pharmacy, University of South Carolina, Columbia, SC, USA., Trujillo AJ; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. |
| Source: | Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2026 Mar; Vol. 60 (2), pp. 346-348. Date of Electronic Publication: 2025 Nov 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2168-4804 (Electronic) Linking ISSN: 21684790 NLM ISO Abbreviation: Ther Innov Regul Sci Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 2168-4804 |
|---|---|
| DOI: | 10.1007/s43441-025-00897-6 |
